Our editorial team avoided the Oktoberfest beerhalls of Munich in favour of the Frankfurt Messe and CPhI 2013. Though the journey from Frankfurt Hahn airport to the city centre was longer than the flight from our office in Montpellier (and almost our New York office too) the show produced a wide range of newsworthy stories:
05-Nov-2013 - A new tableting excipient eliminates the need for wet granulation and saves up to 60% on overall manufacturing costs according to developer Dow.
30-Oct-2013 - Piramal’s COO Vijay Shah described antibody-drug conjugates (ADCs) as “a concept whose time has come” at the CPhI annual report press conference and recent investors in the technology echo his words....
29-Oct-2013 - French CMO Novasep has received the thumbs up from US regulators at two of its European API manufacturing facilities.
28-Oct-2013 - Dow says the acquisition of partner Bend Research is “good news” and will strengthen its developments in solving solubility and bioavailability issues in drug formulation.
28-Oct-2013 - Regulatory pressure for risk-based supply chain management is increasing excipient suppliers’ audit burden according to the team preparing to launch the 'excipact' certification scheme as an independent association.
23-Oct-2013 - Patheon brought in McKinsey consultants over the last three years to help overhaul its sagging business and institute a number of simple process changes that resulted in deep transformations.
23-Oct-2013 - Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit.
23-Oct-2013 - A project to minimise the hold-up volume and losses in the fill/finish of biologics has reduced biologic waste ten-fold, says Cobra Biologics.
21-Oct-2013 - Drugmakers, fine chemicals firms, delivery technology manufacturers and processing system developers from around the world meet in Frankfurt, Germany.